Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 6/2021

01-06-2021 | Atrial Fibrillation | Review

Atrial fibrillation ablation strategies and technologies: past, present, and future

Authors: Thomas J. Buist, Douglas P. Zipes, Arif Elvan

Published in: Clinical Research in Cardiology | Issue 6/2021

Login to get access

Abstract

Catheter ablation is an established treatment option for atrial fibrillation (AF), and pulmonary vein isolation (PVI) has become the gold standard in AF ablation. AF recurrence after PVI remains an important clinical problem. Recovery of conduction from the pulmonary veins (PVs) is considered the dominant mechanism for AF recurrence in paroxysmal AF. However, the underlying mechanism of AF recurrence after PVI is more complex in patients with persistent and longstanding persistent AF. Different ablation technologies and energy sources have been developed aimed at improving lesion quality and durability with an acceptable safety profile. Novel technologies are under evaluation which have a great potential to produce permanent PVI after a single ablation procedure. However, clinical value of these novel devices needs to be tested in adequately powered randomized controlled trials. In this article, we review the history of catheter ablation for AF and discuss the present and future ablation technologies.
Literature
1.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim Y-H, McAnulty JHJ, Zheng Z-J, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJL (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129(8):837–847PubMed
2.
Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B (2000) The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 36(4):1303–1309PubMed
3.
Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, Tsang TSMM (2007) Mortality trends in patients diagnosed with first atrial fibrillation: a 21 year community-based study. J Am Coll Cardiol 49(9):986–992PubMed
4.
Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82(8A):2N-9NPubMed
5.
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920–2925PubMed
6.
Sheikh A, Patel NJ, Nalluri N, Agnihotri K, Spagnola J, Patel A et al (2015) Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis 58(2):105–116PubMed
7.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666PubMed
8.
Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L et al (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Hear Rhythm 14(10):e275-444
9.
Durrer D, Schoo L, Schuilenburg RM, Wellens HJ (1967) The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation 36:644–662PubMed
10.
Morris SN, Zipes DP (1973) His bundle electrocardiography during bidirectional tachycardia. Circulation 48(1):32–36PubMed
11.
Wellens HJ, Durrer D (1975) The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome. Circulation 52(1):58–72PubMed
12.
Wellens HJ (1978) Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 57(5):845–853PubMed
13.
Vedel J, Frank R, Fontaine G, Fournial JF, Grosgogeat Y (1979) Permanent intra-hisian atrioventricular block induced during right intraventricular exploration. Arch Mal Coeur Vaiss 72(1):107–112PubMed
14.
Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 248(7):851–855PubMed
15.
Morady F, Scheinman MM (1984) Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome. N Engl J Med 310(11):705–707PubMed
16.
Silka MJ, Gillette PC, Garson A, Zinner A (1985) Transvenous catheter ablation of a right atrial automatic ectopic tachycardia. J Am Coll Cardiol 5(4):999–1001PubMed
17.
Hartzler GO (1983) Electrode catheter ablation of refractory focal ventricular tachycardia. J Am Coll Cardiol 2(6):1107–1113PubMed
18.
Fisher JD, Brodman R, Kim SG, Matos JA, Elizabeth Brodman L, Wallerson D, Waspe LE (1984) Attempted nonsurgical electrical ablation of accessory pathways via the coronary sinus in the Wolff-Parkinson-White syndrome. J Am Coll Cardiol 4(4):685–694PubMed
19.
Warin JF, Haissaguerre M, Lemetayer P, Guillem JP, Blanchot P (1988) Catheter ablation of accessory pathways with a direct approach. Results in 35 patients. Circulation 78(4):800–815PubMed
20.
Evans GT, Scheinman MM, Zipes DP, Benditt D, Camm AJ, El-Sherif N, Fisher J, Fontaine G, German L, Hartzler G, Josephson M, Morady F, Ruskin J (1986) Catheter ablation for control of ventricular tachycardia: a report of the percutaneous cardiac mapping and ablation registry. Pacing Clin Electrophysiol 9(6):1391–1395PubMed
21.
Rosenqvist M, Lee MA, Moulinier L, Springer MJ, Abbott JA, Wu J, Langberg JJ, Griffin JC, Scheinman MM (1990) Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 16(6):1467–1474
22.
Coltorti F, Bardy GH, Reichenbach D, Greene HL, Thomas R, Breazeale DG, Alferness C, Ivey TD (1985) Catheter-mediated electrical ablation of the posterior septum via the coronary sinus: electrophysiologic and histologic observations in dogs. Circulation 72(3):612–622PubMed
23.
Bardy GH, Ivey TD, Coltorti F, Stewart RB, Johnson G, Greene HL (1988) Developments, complications and limitations of catheter-mediated electrical ablation of posterior accessory atrioventricular pathways. Am J Cardiol 61(4):309–316PubMed
24.
Bardy GH, Coltorti F, Stewart RB, Greene HL, Ivey TD (1988) Catheter-mediated electrical ablation: the relation between current and pulse width on voltage breakdown and shock-wave generation. Circ Res 63(2):409–414PubMed
25.
Jackman WM, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, Margolis PD, Calame JD, Overholt ED, Lazzara R (1991) Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White Syndrome) by radiofrequency current. N Engl J Med 324(23):1605–1611PubMed
26.
Kuck KH, Schlüter M, Geiger M, Siebels J, Duckeck W (1991) Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet (London, England) 337(8757):1557–1561
27.
Calkins H, Sousa J, El-Atassi R, Rosenheck S, de Buitleir M, Kou WH, Kadish AH, Langberg JJ, Morady F (1991) Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med 324(23):1612–1618PubMed
28.
Hindricks G (1993) The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of C. Eur Heart J. 14(12):1644–1653PubMed
29.
Scheinman MM (1995) NASPE survey on catheter ablation. Pacing Clin Electrophysiol 18(8):1474–1478PubMed
30.
Cox JL, Canavan TE, Schuessler RB, Cain ME, Lindsay BD, Stone C, Smith PK, Corr PB, Boineau JP (1991) The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 101(3):406–426PubMed
31.
Sundt TM, Camillo CJ, Cox JL (1997) The maze procedure for cure of atrial fibrillation. Cardiol Clin 15(4):739–748PubMed
32.
Schuessler RB, Grayson TM, Bromberg BI, Cox JL, Boineau JP (1992) Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium. Circ Res 71(5):1254–1267PubMed
33.
Schuessler RB, Kawamoto T, Hand DE, Mitsuno M, Bromberg BI, Cox JL, Boineau JP (1993) Simultaneous epicardial and endocardial activation sequence mapping in the isolated canine right atrium. Circulation 88(1):250–263PubMed
34.
Allessie MA, Bonke FI, Schopman FJ (1977) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The “leading circle” concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 41(1):9–18PubMed
35.
Allessie M, Lammers W, Smeets J, Bonke F, Hollen J (1982) Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart. In: Olsson SB, Schlepper M (eds) Kulbertus HE. Atr Fibrillation Molndal, Sweden Lindgren Soner, pp 4–62
36.
Allessie M, Lammers W, Bonke F, Hollen J (1985) Experimental evaluation of Moe’s multiple wavelet hypothesis of atrial fibrillation. In: Jalife J (ed) Zipes DP. Card Electrophysiol Arrhythmias New York, Grune Strat, pp 265–275
37.
Cox JL, Jaquiss RDB, Schuessler RB, Boineau JP (1995) Modification of the maze procedure for atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 110(2):485–495PubMed
38.
Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt TM, Cox JL, Damiano RJ (2003) The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 126(6):1822–1827PubMed
39.
Morillo CA, Klein GJ, Jones DL, Guiraudon CM (1995) Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91(5):1588–1595PubMed
40.
Elvan A, Pride HP, Eble JN, Zipes DP (1995) Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. Circulation 91(8):2235–2244PubMed
41.
Haïssaguerre M, Gencel L, Fischer B, Le Métayer P, Poquet F, Marcus FI, Clémenty J (1994) Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 5(12):1045–1052PubMed
42.
Swartz JF, Pellersels G, Silvers J, Patten L, Cervantez D (1993) A catheter-based curative approach to atrial fibrillation in humans [abstract]. Circulation 88(Suppl I):I-335
43.
Haïssaguerre M, Jaís P, Shah DC, Gencel L, Pradeau V, Garrigues S, Chouairi S, Hocini M, Métayer P, Roudaut R, Clémenty J (1996) Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 7(12):1132–1144PubMed
44.
Jais P, Shah DC, Takahashi A, Hocini M, Haissaguerre M, Clementy J (1998) Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 21(11):2533–2538PubMed
45.
Natale A, Leonelli F, Beheiry S, Newby K, Pisano E, Potenza D, Rajkovich K, Wides B, Cromwell L, Tomassoni G (2000) Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy: long-term results. Pacing Clin Electrophysiol 23(2):224–233PubMed
46.
Jaïs P, Haïssaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Cle´menty J (1997) A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95(3):572–576PubMed
47.
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S (2000a) Circumferential radiofrequency ablation of pulmonary vein ostia. Circulation 102(21):2619–2628PubMed
48.
Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul S, Punlee K, Kangkagate C (2003) A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 86(Suppl 1):S8-16PubMed
49.
Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al (2005) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. JAMA 293(21):2634PubMed
50.
Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M (2008) Catheter ablation versus antiarrhythmic drugs for atrial fibrillation. Circulation 118(24):2498–2505PubMed
51.
Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfieri O (2003) Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42(2):185–197PubMed
52.
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S (2000b) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102(21):2619–2628PubMed
53.
Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43(11):2044–2053PubMed
54.
Jaïs P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, Macle L, Raybaud F, Garrigue S, Shah DC, Le MP, Clémenty J, Haïssaguerre M (2004) Technique and results of linear ablation at the mitral isthmus. Circulation 110(19):2996–3002PubMed
55.
Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB et al (2015) Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythmia Electrophysiol 8(1):18–24
56.
Zhao Y, Di Biase L, Trivedi C, Mohanty S, Bai R, Mohanty P et al (2016) Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Hear Rhythm 13(1):141–149
57.
Verma A, Jiang C, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque J-P, Nardi S, Menardi E, Novak P, Sanders P, STAR AF II Investigators (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372(19):1812–1822PubMed
58.
Kottkamp H, Schreiber D (2016) The substrate in “early persistent” atrial fibrillation: arrhythmia induced, risk factor induced, or from a specific fibrotic atrial cardiomyopathy? JACC Clin Electrophysiol 2(2):140–142PubMed
59.
Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM (2013) Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation. J Am Coll Cardiol 62(2):138–147PubMedPubMedCentral
60.
Chen P-S, Chen LS, Fishbein MC, Lin S-F, Nattel S (2014) Role of the autonomic nervous system in atrial fibrillation. Circ Res 114(9):1500–1515PubMedPubMedCentral
61.
Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE et al (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA 321(13):1261PubMedPubMedCentral
62.
Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL; CABANA Investigators (2019) Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321(13):1275–1285PubMedPubMedCentral
63.
Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133(17):1637–1644PubMed
64.
Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427PubMed
65.
Haines DE (1993) The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol 16(3):586–591PubMed
66.
Nakagawa H, Yamanashi WS, Pitha JV, Arruda M, Wang X, Ohtomo K, Beckman KJ, McClelland JH, Lazzara R, Jackman WM (1995) Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation 91(8):2264–2273PubMed
67.
Yokoyama K, Nakagawa H, Shah DC, Lambert H, Leo G, Aeby N, Ikeda A, Pitha JV, Sharma T, Lazzara R, Jackman WM (2008) Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol 1(5):354–362PubMed
68.
Arujuna A, Karim R, Caulfield D, Knowles B, Rhode K, Schaeffter T, Kato B, Rinaldi CA, Cooklin M, Razavi R, O’Neill MD, Gill J (2012) Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging. Circ Arrhythm Electrophysiol 5(4):691–700PubMed
69.
Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE (2003) Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J Cardiovasc Electrophysiol 14(7):685–690PubMed
70.
Callans DJ, Gerstenfeld EP, Dixit S, Zado E, Vanderhoff M, Ren J-F, Marchlinski FE (2004) Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation. J Cardiovasc Electrophysiol 15(9):1050–1055PubMed
71.
Buist TJ, Adiyaman A, Smit JJJ, Ramdat Misier AR, Elvan A (2018) Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation. Clin Res Cardiol. 107(6):498–506PubMed
72.
Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE (2014) Paroxysmal AF catheter ablation with a contact force sensing catheter. J Am Coll Cardiol 64(7):647–656PubMed
73.
Kuck K-H, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jaïs P, Nakagawa H, Lambert H, Shah DC (2012) A novel radiofrequency ablation catheter using contact force sensing: toccata study. Hear Rhythm 9(1):18–23
74.
Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque J-P, Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert H, Mansour M (2015) Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation. Circulation 132(10):907–915PubMed
75.
Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K et al (2013) In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010. Circulation 128(19):2104–2112PubMed
76.
Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M et al (2005) Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol 16(6):576–581PubMed
77.
Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L, Benussi S, Alfieri O, Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F (2004) Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 109(22):2724–2726PubMed
78.
Tamborero D, Mont L, Nava S, de Caralt TM, Molina I, Scalise A, Perea RJ, Bartholomay E, Berruezo A, Matiello M, Brugada J (2005) Incidence of pulmonary vein stenosis in patients submitted to atrial fibrillation ablation: a comparison of the selective segmental ostial ablation vs the circumferential pulmonary veins ablation. J Interv Card Electrophysiol 14(1):21–25PubMed
79.
Herrera Siklódy C, Deneke T, Hocini M, Lehrmann H, Shin DI, Miyazaki S, Henschke S, Fluegel P, Schiebeling-Römer J, Bansmann PM, Bourdias T, Dousset V, Hassaguerre M, Arentz T (2011) Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 58(7):681–688PubMed
80.
Haines DE, Stewart MT, Ahlberg S, Barka ND, Condie C, Fiedler GR, Kirchhof NA, Halimi F, Deneke T (2013) Microembolism and catheter ablation I: a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia. Circ Arrhythmia Electrophysiol 6(1):16–22
81.
Boersma LV, van der Voort P, Debruyne P, Dekker L, Simmers T, Rossenbacker T, Balt J, Wijffels M, Degreef Y (2016) Multielectrode pulmonary vein isolation versus single tip wide area catheter ablation for paroxysmal atrial fibrillation: a multinational multicenter randomized clinical trial. Circ Arrhythm Electrophysiol 9(4):e003151PubMed
82.
De Ponti R (2005) Cryothermal energy ablation of cardiac arrhythmias 2005: state of the art. Indian Pacing Electrophysiol J 5(1):12–24PubMedPubMedCentral
83.
Kuck K-H, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KRJ, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque J-P, Tondo C (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374(23):2235–2245PubMed
84.
Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN, STOP AF Cryoablation (2013) Investigators cryoballoon. Ablation of pulmonary veins for paroxysmal atrial fibrillation. J Am Coll Cardiol 61(16):1713–1723PubMed
85.
Kuck K-H, Furnkranz A, Chun KRJ, Metzner A, Ouyang F, Schluter M, Elvan A, Lim HW, Kueffer FJ, Arentz T, Albenque J-P, Tondo C, Kuhne M, Sticherling C, Brugada J (2016) Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J 37(38):2858–2865PubMedPubMedCentral
86.
Heeger C, Pott A, Rillig A, Metzner A, Cay S, Grosse N, Miyazaki S, Arash A, Ehrlich J, Wirth H, Tscholl V, Kuck K, Dahm T, Tilz R (2019) Phrenic nerve injury during pulmonary vein isolation using the second-generation cryoballoon: first results of the worldwide YETI registry. Abstract presented at: European Heart Rhythm Association Congress, Lisbon, Portugal.
87.
Dukkipati SR, Cuoco F, Kutinsky I, Aryana A, Bahnson TD, Lakkireddy D, Woollett I, Issa ZF, Natale A, Reddy VY (2015) Pulmonary vein isolation using the visually guided laser balloon: a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol 66(12):1350–1360PubMed
88.
Bordignon S, Chun K-RJ, Gunawardene M, Urban V, Kulikoglu M, Miehm K, Brzank B, Schulte-Hahn B, Nowak B, Schmidt B (2013) Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study. EP Eur 15(5):685–689
89.
Reynolds MR, Zheng Q, Doros G (2018) Laser balloon ablation for AF: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 29(10):1363–1370PubMed
90.
El Haddad M, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R, Knecht S, Vandekerckhove Y, Tavernier R, Nakagawa H, Duytschaever M (2017) Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythmia Electrophysiol 10(4):e004867
91.
Santoro F, Metzner A, Brunetti ND, Heeger CH, Mathew S, Reissmann B, Lemeš C, Maurer T, Fink T, Rottner L, Inaba O, Kuck KH, Ouyang F, Rillig A (2019) Left atrial anterior line ablation using ablation index and inter-lesion distance measurement. Clin Res Cardiol 108(9):1009–1016PubMed
92.
Nakagawa H, Jackman WM (2014) The role of contact force in atrial fibrillation ablation. Journal of Atrial Fibrillation. 7:78–84 ((CardioFront LLC))
93.
Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, Waktare JEP, Todd DM, Hall MCS, Snowdon RL, Modi S, Gupta D (2017) Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace 19(5):775–783PubMed
94.
Hussein A, Das M, Riva S, Morgan M, Ronayne C, Sahni A, Shaw M, Todd D, Hall M, Modi S, Natale A, Dello Russo A, Snowdon R, Gupta D (2018) Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients. Circ Arrhythm Electrophysiol 11(9):e006576PubMed
95.
Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, Tavernier R, Duytschaever M (2018) Improving procedural and 1 year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. EP Eur. 20(FI_3):f419–f427
96.
Pranata R, Vania R, Huang I (2019) Ablation-index guided versus conventional contact-force guided ablation in pulmonary vein isolation—systematic review and meta-analysis. Indian Pacing Electrophysiol J 19(4):155–160PubMedPubMedCentral
97.
Barkagan M, Contreras-Valdes FM, Leshem E, Buxton AE, Nakagawa H, Anter E (2018) High-power and short-duration ablation for pulmonary vein isolation: safety, efficacy, and long-term durability. J Cardiovasc Electrophysiol 29(9):1287–1296PubMed
98.
Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G, Salcedo J, Trivedi CG, Gianni C, Jais P, Natale A, Day JD (2019) Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations. Hear Rhythm 16(2):165–169
99.
Vassallo F, Cunha C, Serpa E, Meigre LL, Carloni H, Simoes A, Hespanhol D, Lovatto CV, Batista W, Serpa R (2019) Comparison of high-power short-duration (HPSD) ablation of atrial fibrillation using a contact force-sensing catheter and conventional technique: initial results. J Cardiovasc Electrophysiol 30(10):1877–1883PubMed
100.
Ali-Ahmed F, Goyal V, Patel M, Orelaru F, Haines DE, Wong WS (2019) High-power, low-flow, short-ablation duration—the key to avoid collateral injury? J Interv Card Electrophysiol 55(1):9–16PubMed
101.
Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Pürerfellner H (2019) Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol 5(7):778–786PubMed
102.
Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, Telishevska M, Otgonbayar U, Koch-Büttner K, Lennerz C, Bartkowiak M, Kornmayer M, Rousseva E, Brkic A, Grebmer C, Kolb C, Hessling G, Deisenhofer I (2020) Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol 22(3):388–393
103.
Reddy VY, Schilling R, Grimaldi M, Horton R, Natale A, Riva S, Tondo C, Kuck K-H, Neuzil P, McInnis K, Bishara M, Zhang B, Govari A, Abdelaal A, Mansour M (2019) Pulmonary vein isolation with a novel multielectrode radiofrequency balloon catheter that allows directionally tailored energy delivery: short-term outcomes from a multicenter first-in-human study (RADIANCE). Circ Arrhythm Electrophysiol 12(12):e007541PubMed
104.
105.
Kottkamp H, Moser F, Rieger A, Schreiber D, Pönisch C, Trofin M (2017) Global multielectrode contact mapping plus ablation with a single catheter: preclinical and preliminary experience in humans with atrial fibrillation. J Cardiovasc Electrophysiol 28(11):1247–1256PubMed
106.
Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306(4):194–200PubMed
107.
du Pre BC, van Driel VJ, van Wessel H, Loh P, Doevendans PA, Goldschmeding R, Wittkampf FH, Vink A (2013) Minimal coronary artery damage by myocardial electroporation ablation. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol 15(1):144–149
108.
van Driel VJHM, Neven K, van Wessel H, Vink A, Doevendans PAFM, Wittkampf FHM (2015) Low vulnerability of the right phrenic nerve to electroporation ablation. Hear Rhythm 12(8):1838–1844
109.
Neven K, van Es R, van Driel V, van Wessel H, Fidder H, Vink A, Doevendans P, Wittkampf F (2017) Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus. Circ Arrhythm Electrophysiol 10(5):e004672PubMed
110.
111.
Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P (2019) Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 74(3):315–326PubMed
112.
Reddy VY, Koruth J, Jais P, Petru J, Timko F, Skalsky I, Hebeler R, Labrousse L, Barandon L, Kralovec S, Funosako M, Mannuva BB, Sediva L, Neuzil P (2018) Ablation of atrial fibrillation with pulsed electric fields. JACC Clin Electrophysiol 4(8):987–995PubMed
113.
Koruth JS, Schneider C, Avitall B, Ribeiro L, Dukkipati S, Walcott GP, Phillips P, McElderry HT, Reddy VY (2015) Pre-clinical investigation of a low-intensity collimated ultrasound system for pulmonary vein isolation in a porcine model. JACC Clin Electrophysiol 1(4):306–314PubMed
Metadata
Title
Atrial fibrillation ablation strategies and technologies: past, present, and future
Authors
Thomas J. Buist
Douglas P. Zipes
Arif Elvan
Publication date
01-06-2021
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 6/2021
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01751-5

Other articles of this Issue 6/2021

Clinical Research in Cardiology 6/2021 Go to the issue

Correction

Correction to: Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study

Review

Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI

Original Paper

Epicardial access for VT ablation: analysis of two different puncture techniques, incidence of adhesions and complication management

Original Paper

Left-lateral thoracotomy for catheter ablation of scar-related ventricular tachycardia in patients with inaccessible pericardial access

Original Paper

Sinus heart rate post pulmonary vein ablation and long-term risk of recurrences

Letter to the Editors

Substrate characterization for ventricular tachycardia ablation using a new image processing service

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits